Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Koustenis AG"'
Publikováno v:
In Value in Health 2010 13(3):A28-A28
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Patel JD; Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL. Electronic address: jpatel25@medicine.bsd.uchicago.edu., Paz-Ares L; University Hospital Doce de Octubre & Research Institute, Madrid, Spain., Zinner RG; Department of Medical Oncology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA., Barlesi F; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Marseille, France., Koustenis AG; Oncology at Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN., Obasaju CK; Oncology at Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2018 Nov; Vol. 19 (6), pp. e823-e830. Date of Electronic Publication: 2018 May 26.
Autor:
Zinner RG; Department of Investigational Cancer therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, Texas; †Global Diversity/Med Affairs, Eli Lilly and Company, Indianapolis, Indiana; ‡Medical Oncology, Tennessee Oncology, Nashville, Tennessee; §Hematology/Oncology, Florida Cancer Specialists, Fort Myers, Florida; •Medical Oncology, Highlands Oncology Group, Fayetteville, Arkansas; ¶Hematology-Medical Oncology, Oncology Heamatology Care Inc., Blue Ash, Ohio; #Hematology & Oncology, Internal Medicine, ACRC/Arizona Clinical Research Center, Arizona Oncology, Tucson, Arizona; **Hematology and Oncology, Michigan State University, East Lansing, Michigan; ††Northeast Georgia Cancer Care, University of Georgia Health Sciences University, Athens, Georgia; ‡‡Statistics Oncology, §§CDK4/6 Product Team, GPORWE-Oncology, ¶¶Oncology-Global Strategic Plan, ##Oncology-Early Phase, ***US Med Affairs and Late Phase Prod Dev, †††Global Medical Communications-Oncology, and ‡‡‡Global Med Affairs & Late Phase Prod Dev, Eli Lilly and Company, Indianapolis, Indiana; §§§Department of Medicine, Oncology Division, Washington University Medical School, St. Louis, Missouri; and ••Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Obasaju CK, Spigel DR, Weaver RW, Beck JT, Waterhouse DM, Modiano MR, Hrinczenko B, Nikolinakos PG, Liu J, Koustenis AG, Winfree KB, Melemed SA, Guba SC, Ortuzar WI, Desaiah D, Treat JA, Govindan R, Ross HJ
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2015 Jan; Vol. 10 (1), pp. 134-42.